Publicacións en colaboración con investigadores/as de University of Bordeaux (3)

2023

  1. Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)

    Nature Medicine

2022

  1. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

    European Urology, Vol. 82, Núm. 2, pp. 212-222

2017

  1. Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer

    Cancer Research, Vol. 77, Núm. 21, pp. 5846-5859